Article
A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts.
Journal of inherited metabolic disease - 1 Feb 2009
Steinberg S J, Snowden A, Braverman N E, Chen L, Watkins P A, Clayton P T, Setchell K D R, Heubi J E, Raymond G V, Moser A B, Moser H W
Abstract excerpt
Zellweger spectrum disorders (ZSD) are diagnosed by biochemical assay in blood, urine and cultured fibroblasts and PEX gene mutation identification. In most cases studies in fibroblasts corroborate results obtained in body fluids. In 1996 Clayton and colleagues described a 10-year old girl with evidence of a peroxisome disorder, based on elevated bile acid metabolites and phytanate. At the time it was not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
